The Ministry of Health of the Russian Federation reissued the registration certificate No. LSR-003817/08 for the drug Teofedrin® tablets No. 10 manufactured by
the FSUE Moscow Endocrine Plant.
The drug belongs to the pharmacotherapeutic group: a combined bronchodilating agent used as an adjunct for respiratory diseases accompanied by bronchospasm (bronchial asthma, chronic obstructive bronchitis, pulmonary emphysema).
Taking into account the social significance and in connection with the receipt of a large number of letters from citizens of the Russian Federation regarding the absence of circulation of the drug for medical use Teofedrin-N®, tablets, the Enterprise announces the launch of the drug in mid-October of 2017.
Comment type is not specified in the component properties.